Blog
/
Patient Engagement
Patient Engagement Guide

Biometric Data in Behavioral Health: How Wearables Help Care Teams Catch Risk Earlier

Sleep, activity and heart rate data can help care teams spot risk between visits and after discharge. Here is what the evidence supports, how HIPAA and Part 2 apply, and how to roll it out without alert fatigue.

On this page
See Verity in action

A 30-minute walkthrough using the systems you already run.

Book a Demo

Key takeaways

  • Biometric data in behavioral health works best as an early-warning layer. Changes in sleep, activity and heart rate can prompt a timely check-in, but they do not diagnose relapse or depression on their own.
  • Evidence is strongest for sleep disruption and lower heart rate variability as markers of stress, craving and relapse risk. Algorithmic depression detection is promising but not ready to stand alone.
  • Consumer wearable data becomes protected health information once your organization receives it, and SUD programs covered by 42 CFR Part 2 must apply Part 2 as well.
  • Start small: one high-risk population, a few signals, named alert owners and clear consent. Check the 2027 RPM and RTM rules before counting on reimbursement.
  • Verity connects Fitbit, Apple Health and Garmin data during treatment and after discharge, flags changes in sleep, activity or check-ins so staff can reach out early, and pairs those signals with engagement, contingency management, measurement-based care and workflow alerts. Organizations can also deploy the platform in their own programs.

Biometric data in behavioral health has moved from research labs to patients' wrists and fingers. Many people entering residential, IOP, PHP or outpatient care already wear a device that records sleep, activity and heart rate. For executives and clinical leaders, the question is no longer whether this data exists. It is whether it can help a care team notice that a high-risk patient is struggling days before a missed appointment, a positive screen or a crisis call.

The answer is a qualified yes. Wearables will not replace clinical judgment, toxicology or validated assessments, but they add a continuous signal between those touchpoints, especially in the weeks after discharge. This guide covers the market, the evidence, HIPAA, Part 2 and billing rules, and how to roll out a program without burying staff in alerts.

How Verity helps

Verity for Patients brings wearable data into the same platform programs already use for engagement and outcomes, with a focus on high-risk populations such as residential discharges, IOP and PHP step-downs, and substance use treatment.

  • Connect the devices patients already wear. Patients connect wearables like Fitbit, Apple Health and Garmin, and sleep, activity and heart rate sync automatically, during treatment and after discharge.
  • Catch warning signs early. Changes in sleep, activity or check-ins can flag early warning signs, so your team can reach out before a crisis.
  • See signals in context. Wearable trends sit alongside PHQ-9 and GAD-7 results from measurement-based care, engagement history and contingency management rewards.
  • Route the follow-up.Workflow automation turns patient actions into automatic alerts and follow-ups, and routes tasks to the right staff member.
  • Stay connected after discharge. Patients keep the app, so check-ins, rewards and support continue once they leave your care.

Verity also offers the platform for other organizations, including health plans and provider networks, to deploy in their own programs. See how it fits residential treatment, IOP and PHP programs, substance use treatment programs and health plans, or start with the Verity for Patients platform overview.

Why is biometric data entering behavioral health now?

Consumer platforms are adding mental health features, wearable companies are moving into clinical care, and researchers are building sensors for substance use risks.

Consumer platforms are adding mental health features

With iOS 17 and watchOS 10, Apple added mood logging and "the same depression and anxiety assessments often used in clinics" to the Health app (Apple). Becker's identified those assessments as the PHQ-9 and GAD-7. Google's Fitbit Body Response feature on the Sense 2 uses electrodermal activity, heart rate, heart rate variability (HRV) and skin temperature to flag possible stress (Google).

Oura is moving from tracking to care

Oura, the smart ring company, has grown through acquisitions, including Proxy in 2023 and metabolic health startup Veri and Sparta Science in 2024 (TechCrunch). In October 2025 it launched Cumulative Stress, a score built from a month of sleep, heart stress-response, temperature and activity data (TechCrunch). In April 2026 it acquired Galen AI, which links wearable data with medical records (the5krunner).

The biggest move came on November 10, 2026, when Oura announced it would acquire Counsel Health, an AI-native, physician-supervised care platform. Oura said the deal moves it "from helping members understand their health to enabling them to act on it," with care delivered inside the Oura app (Oura). Bloomberg reported the price at $625 million (via Let's Data Science). Oura has not framed the deal around behavioral health, but wearable data is clearly becoming a front door to clinical care.

Substance use sensors are in development

A review in Current Addiction Reports found wearable sensors were the most commonly studied mobile technology for substance use disorder, with uses including stress and craving detection, opioid intake detection and overdose monitoring (Goldfine et al., 2020). In Australia, a study at two supervised injecting facilities is training a chest-worn sensor to detect opioid-induced respiratory depression (JMIR Research Protocols, 2024). Continuous alcohol monitoring is already established in justice settings: the SCRAM CAM ankle bracelet tests sweat for alcohol every 30 minutes (SCRAM Systems).

What can biometric data in behavioral health actually tell you?

Some signals have decades of research behind them. Others are promising but immature.

SignalWhat the research showsHow to use it today
Sleep (onset, duration, continuity)Sleep problems, especially difficulty falling asleep, have long been linked to relapse risk in alcohol use disorder (Brower, 2001).Strong candidate for early-warning rules and check-in prompts.
Heart rate variabilityA 2024 review of 14 studies found lower resting HRV in people who use substances, associated with higher stress, craving and symptom severity (Moon et al., 2024).Trend each patient against their own baseline. Do not compare across patients or devices.
Activity and stepsActivity data is a common input to wearable depression models, and sharp drops can reflect low mood, withdrawal or disengagement.Use with check-ins. Injury, a new job or weather can explain a drop.
Algorithm-based depression detectionA 2023 meta-analysis of 54 studies found accuracy between 0.70 and 0.89, with small samples and very high heterogeneity. The authors said wearable AI should be combined with questionnaires or interviews (Abd-Alrazaq et al., npj Digital Medicine).Never treat as a diagnosis. Pair with the PHQ-9 and clinical review.
Overdose and withdrawal detectionEarly-stage sensor and algorithm studies (see above).Watch the field. Not yet standard of care.

The most reliable use is change detection within one patient. Someone whose sleep falls from seven hours to four for several nights, whose steps collapse, and who skips two check-ins is worth a call.

Which patients benefit most from wearable monitoring?

  • Residential discharges. The first weeks home are high risk, and contact drops sharply at discharge. Wearables extend visibility past the last day on the unit.
  • IOP and PHP step-downs. As weekly contact hours fall, continuous data helps fill the gaps between sessions.
  • SUD and opioid treatment patients. Sleep and stress signals are relevant to craving and relapse, and pair naturally with contingency management.
  • CCBHC and health plan populations. Care managers with large panels can use a change in sleep or activity, plus a missed visit, to decide who to call first.

Want early warning signs routed to the right staff member?See how Verity connects wearables to your programs.

How do HIPAA and 42 CFR Part 2 apply to wearable data?

A consumer wearable's data is generally outside HIPAA while it sits only in the patient's own app. That changes when your organization receives it: once identifiable data from a patient's device lands in a covered entity's systems, it is protected health information. HHS guidance also says that when a covered entity provides or contracts for a remote monitoring app, the developer is a business associate (summary of HHS OCR FAQs). In practice:

  • Sign a business associate agreement with every vendor that receives, stores or processes wearable data for you.
  • Collect only what you will use. Daily sleep, activity and heart rate summaries are usually enough.
  • For SUD programs subject to 42 CFR Part 2, treat wearable data collected as part of treatment as part of the patient's SUD record. The 2024 final rule allows a single patient consent for treatment, payment and health care operations, aligns enforcement with HIPAA, and set a February 16, 2026 compliance date (HHS).
  • Write consent in plain language: what is collected, who sees it, what happens when an alert fires, that monitoring is not an emergency service, and that patients can disconnect without losing care.

Can you bill for remote monitoring in behavioral health?

Sometimes, and the rules are tightening. Medicare pays for two families of codes: remote patient monitoring (RPM), for physiologic data such as heart rate, and remote therapeutic monitoring (RTM), for therapeutic data. For 2026, CMS added codes for 2 to 15 days of readings and a 10-minute management tier, including CPT 99445 and 99470 for RPM (ChronicCareIQ).

The CY 2027 final rule, issued November 4, 2026, limits RTM to established patients and requires a face-to-face initiating visit, in person or by telehealth, before RPM or RTM begins, starting January 1, 2027. A requirement that billable monitoring time come from clinical staff who are direct employees of the billing practice was delayed to January 1, 2029, and several device and data codes face practice expense cuts phased in over at least two years (Nixon Peabody). Our 2027 fee schedule guide covers the wider impact.

Device and documentation requirements are specific, so confirm with your billing team whether a consumer device qualifies, and remember that Medicaid and commercial coverage vary. For most programs, the stronger case is clinical and operational: earlier outreach and better post-discharge outcome data.

What does a missed early warning cost?

Illustration, not a statistic. Consider a program that discharges 30 patients a month. Assume 6 of them show a sustained drop in sleep or activity during their first month home. If earlier outreach helped even one of those six avoid a readmission each month, multiply your own average cost of a readmission or crisis episode by 12 to estimate the annual effect. Then subtract staff time: at 15 minutes to review and act on each alert, six alerts a month is about 1.5 staff hours. Use your own volumes and costs. The point is to compare a small, predictable staff cost with a large, unpredictable one.

How do you implement a wearable program in behavioral health?

  1. Pick one population and one question. For example: "For residential discharges in their first 60 days, can we reach patients before they disengage?"
  2. Choose a few signals. Start with sleep, activity and heart rate, plus app check-ins.
  3. Set personal baselines. Collect one to two weeks of data per patient before firing alerts, and alert on change from that baseline rather than fixed thresholds.
  4. Define the response. For each alert type, name the owner (peer, case manager, nurse or clinician), the response time and the action, such as a text, call or scheduled visit.
  5. Plan for device access. Decide whether you will loan devices, rely on phone-based activity data, or use check-ins alone for patients without a wearable.
  6. Connect it to what already works. Reward check-ins through contingency management and pair trends with PHQ-9 and GAD-7 results.
  7. Review monthly. Track alerts per patient, time to outreach, false alarms, and outcomes such as attendance, PHQ-9 change and readmissions. Tune or retire rules that do not lead to action.

Wearable program readiness checklist

  • Business associate agreement in place with every vendor that touches wearable data
  • Part 2 consent language reviewed by counsel (SUD programs)
  • Baseline period and change-based alert rules defined
  • Named owner and response time for every alert type
  • After-hours language making clear monitoring is not an emergency service
  • Loaner device or alternative option for patients without a wearable
  • Plain-language consent, including how to disconnect
  • Baseline outcome data captured before launch, and a monthly review on the calendar

What edge cases should you plan for?

  • Patients without a device. Wearable use is uneven. In a preliminary analysis presented at the American Heart Association's 2022 Scientific Sessions, about 29% of U.S. adults used wearables, and among people with cardiovascular disease, those with household incomes of $50,000 or more were about four times as likely to use one as those earning under $20,000 (AHA). Design the program so non-wearers still get check-ins and outreach.
  • Shared or borrowed devices. Data from a device someone else is wearing will look like your patient's. Confirm at enrollment that the device belongs to the patient.
  • Shift workers and new parents. Disrupted sleep may be normal for them. Personal baselines prevent false alarms.
  • Medication changes. Starting or tapering buprenorphine, methadone, antidepressants or sleep medication can change sleep and heart rate.
  • Justice-involved patients. Make clear that wellness data is used for care, not compliance monitoring, and keep it separate from court-ordered tools such as transdermal alcohol monitors.
  • Missing data. A ring on the charger looks like zero activity. Treat gaps as a prompt for a friendly check-in, not a crisis.

What are the most common mistakes?

  • Alerting on everything. Too many low-value alerts teach staff to ignore all of them.
  • Treating a signal as a diagnosis. Wearable changes prompt a conversation. They do not confirm relapse or depression.
  • No owner. An alert that lands in a shared inbox at 9 p.m. on a Friday helps no one.
  • Ignoring the patient's view. Patients engage when they see their own trends and earn recognition, not when they feel watched.
  • Launching without a baseline. Without pre-launch attendance, readmission and PHQ-9 data, you cannot show the program worked.

Recap

Biometric data in behavioral health is a practical tool for high-risk patients when it is used as an early-warning layer, not a diagnosis. Sleep and HRV have the strongest support; pair algorithmic detection with validated assessments. Treat device data as PHI once you receive it, apply Part 2 where it applies, and check the 2027 RPM and RTM rules before counting on reimbursement. Start with one population, a few signals and clear owners, and review results every month.

To see how wearable signals, check-ins, rewards and assessments work together in one platform, book a demo of Verity.

Does Verity integrate with your EHR?

Verity works with any EHR and connects to 200+ systems through API or secure file transfer, so appointments, attendance, and assessment results flow automatically.

See all integrations →

Frequently asked questions

What biometric data is most useful in behavioral health?

Sleep, activity and heart rate are the most practical starting points. Sleep disruption has long been linked to relapse risk, and lower heart rate variability is associated with stress and craving in people with substance use disorders. Watch for changes from each patient's own baseline, alongside check-ins and validated assessments, rather than fixed thresholds.

Is wearable data covered by HIPAA?

Not while it sits only in a patient's personal app. Once your organization receives identifiable wearable data, it is protected health information, and vendors that store or process it for you need a business associate agreement. SUD programs subject to 42 CFR Part 2 should also treat it as part of the patient's SUD record.

Can wearables predict relapse?

Not on their own. Research links poor sleep and lower heart rate variability to craving and relapse risk, and machine learning models show promise, but accuracy varies and most studies are small. Treat wearable changes as a prompt for outreach and clinical review, not as proof that a patient has relapsed.

Can we bill Medicare for wearable monitoring?

Possibly, through remote patient monitoring or remote therapeutic monitoring codes, but the requirements are specific. From January 2027, RTM is limited to established patients, and both require an initiating visit before monitoring starts. Device rules, documentation and payer policies vary, so confirm eligibility with your billing team before building a program around reimbursement.

How do we avoid alert fatigue?

Start with a few signals, wait for a baseline before alerting, and alert on meaningful change rather than single readings. Give every alert type a named owner and response time. Review alert volume and false alarms monthly, and retire rules that rarely lead to action. Fewer, better alerts are the ones that get answered.

Share this article
LinkedInEmailCopy link

Keep Reading

More guides for behavioral health teams.

CM
Buyer's Guide
Verity for Patients
Contingency Management

Contingency Management Software: A Buyer's Guide for Behavioral Health Programs

CM evidence, OIG and SAMHSA incentive limits, state Medicaid programs, and the vendor questions to ask.

Read Article
No-Shows
9 Strategies
Verity for Patients
Engagement

How to Reduce No-Shows in Behavioral Health: 9 Evidence-Based Strategies

Faster access, better reminders, targeted outreach, CM incentives, measurement-based care, and follow-up.

Read Article
2027
Fee Schedule
All Products
Medicare

2027 Medicare Physician Fee Schedule: What Changes for Behavioral Health

Conversion factor cuts, telehealth, collaborative care, and the new RPM and RTM rules.

Read Article

See Wearable Early Warnings in Action

A 30-minute walkthrough of how Verity connects Fitbit, Apple Health and Garmin data with check-ins, rewards and assessments, and routes early warning signs to your team.

Book a Demo